2024/06/25 22:30:00 | |
---|---|
Price | |
2.085 USD | |
Difference | 5.84% (0.12) |
ISIN | US74275C3043 |
Symbol | PCSA |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 1.90 USD (1,000) |
Ask (Ask size) | 2.12 USD (300) |
Open | 1.9041 USD |
High | 2.14 USD |
Low | 1.9041 USD |
Close (prev. day) | 1.97 USD |
VWAP | 2.032393 USD |
Volume (pcs) | 76,233 |
Trading volume | 154,945.25 |
Number of trades | 350 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings | ||
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings |
2024/06/25 22:30:00 | |
---|---|
Price | |
2.085 USD | |
Difference | 5.84% (0.12) |
ISIN | US74275C3043 |
Symbol | PCSA |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 1.90 USD (1,000) |
Ask (Ask size) | 2.12 USD (300) |
Open | 1.9041 USD |
High | 2.14 USD |
Low | 1.9041 USD |
Close (prev. day) | 1.97 USD |
VWAP | 2.032393 USD |
Volume (pcs) | 76,233 |
Trading volume | 154,945.25 |
Number of trades | 350 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -76.80% | -78.53% | -98.79% |
Perf (abs.) | -6.90 | -7.63 | -170.32 |
Beta | 2.06 | 1.89 | 0.92 |
Volatility | 216.90 | 193.11 | 132.58 |
Ø price 5 days | Ø volume 5 days (pcs.) | 1.933 USD (49,652) |
Ø price 30 days | Ø volume 30 days (pcs.) | 1.817 USD (121,329) |
Ø price 100 days | Ø volume 100 days (pcs.) | 2.104 USD (989,201) |
Ø price 250 days | Ø volume 250 days (pcs.) | 5.519 USD (791,139) |
YTD High | date | 7.400 USD (2024/01/03) |
YTD Low | date | 1.400 USD (2024/04/16) |
52 Weeks High | date | 18.000 USD (2023/10/16) |
52 Weeks Low | date | 1.400 USD (2024/04/16) |
PROCESSA PHARMACEUTICALS |
- - |
Coca Cola Drive, Suite 106 7380 21076 Hanover |
Telefon: +1 443.776.3133 |
Fax: +1 443.288.4420 |
E-mail: ir@processapharma.com |
- |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer